Aurinia Pharmaceuticals Inc. AUPH

Full chart Compare
Set alert

Price alert · AUPH

All alert types
16.56 USD +0.42 (+2.60%)

At closeNov 3, 2026, 4:01 PM EST

16.56 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

16.13 Day range 16.73
13.33 52-week range 19.25
YTD
+3.82%
1 year
+25.74%

Analyst view

Consensus: buy

Buy
Price target (mean) 18.29 +10.4% upside
Target (low)
16.00
Target (mean)
18.29
Target (high)
21.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy5
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

AUPH analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.2140.17 – 0.241.53-86.0%85.57M+11.0%5
Next quarter0.190.17 – 0.210.25-24.0%82.95M+6.8%2
Current year0.970.93 – 1.002.07-53.1%330.19M+16.7%5
Next year1.160.68 – 1.630.97+19.6%388.73M+17.7%5

Upgrades and downgrades

The latest rating changes

AUPH analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2026RBC CapitalMaintainedSector PerformSector Perform
Oct 21, 2026TD CowenMaintainedBuyBuy
Aug 7, 2026RBC CapitalMaintainedSector PerformSector Perform
Dec 3, 2025Leerink PartnersDowngradeOutperformMarket Perform
Nov 7, 2025JefferiesUpgradeHoldBuy
Nov 5, 2025RBC CapitalDowngradeOutperformSector Perform
Aug 1, 2025RBC CapitalMaintainedOutperformOutperform
Sep 16, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Sep 9, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Sep 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Feb 23, 2024Cantor FitzgeraldMaintainedOverweightOverweight
Feb 22, 2024HC Wainwright & Co.MaintainedBuyBuy
Feb 16, 2024RBC CapitalMaintainedOutperformOutperform
Sep 22, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 7, 2023HC Wainwright& Co.MaintainedBuyBuy
Jul 6, 2023Cantor FitzgeraldReiteratedOverweightOverweight
May 3, 2023HC Wainwright & Co.Reiterated—Buy
Feb 23, 2023RBC CapitalReiterated—Outperform
Jan 4, 2023RBC CapitalMaintained—Outperform
Nov 7, 2022HC Wainwright & Co.Maintained—Buy
Nov 4, 2022RBC CapitalMaintained—Outperform
Nov 4, 2022OppenheimerDowngradeOutperformPerform
Nov 4, 2022SVB LeerinkMaintained—Outperform
Aug 9, 2022HC Wainwright & Co.Maintained—Buy
Aug 8, 2022OppenheimerMaintained—Outperform
May 5, 2022HC Wainwright & Co.Maintained—Buy
Apr 28, 2022RBC CapitalMaintained—Outperform
Mar 8, 2022SVB LeerinkMaintained—Outperform
Mar 1, 2022RBC CapitalMaintained—Outperform